Germany
· Delayed Price · Currency is EUR SCHOTT Pharma AG & Co. KGaA Statistics
Total Valuation
SCHOTT Pharma AG & Co. KGaA has a market cap or net worth of EUR 3.66 billion. The enterprise value is 3.92 billion.
| Market Cap | 3.66B |
| Enterprise Value | 3.92B |
Important Dates
The last earnings date was Thursday, December 12, 2024.
| Earnings Date | Dec 12, 2024 |
| Ex-Dividend Date | Feb 5, 2025 |
Share Statistics
| Current Share Class | n/a |
| Shares Outstanding | n/a |
| Shares Change (YoY) | n/a |
| Shares Change (QoQ) | +1.85% |
| Owned by Insiders (%) | n/a |
| Owned by Institutions (%) | n/a |
| Float | 34.64M |
Valuation Ratios
The trailing PE ratio is 24.47.
| PE Ratio | 24.47 |
| Forward PE | n/a |
| PS Ratio | n/a |
| PB Ratio | n/a |
| P/TBV Ratio | 4.82 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 14.74, with an EV/FCF ratio of 48.91.
| EV / Earnings | 26.22 |
| EV / Sales | 4.10 |
| EV / EBITDA | 14.74 |
| EV / EBIT | 19.49 |
| EV / FCF | 48.91 |
Financial Position
The company has a current ratio of 1.35, with a Debt / Equity ratio of 0.36.
| Current Ratio | 1.35 |
| Quick Ratio | 0.68 |
| Debt / Equity | 0.36 |
| Debt / EBITDA | 1.13 |
| Debt / FCF | 3.57 |
| Interest Coverage | 14.78 |
Financial Efficiency
Return on equity (ROE) is 20.26% and return on invested capital (ROIC) is 11.92%.
| Return on Equity (ROE) | 20.26% |
| Return on Assets (ROA) | 8.83% |
| Return on Capital (ROIC) | 11.92% |
| Revenue Per Employee | 207,882 |
| Profits Per Employee | 32,512 |
| Employee Count | 4,646 |
| Asset Turnover | 0.72 |
| Inventory Turnover | 4.54 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -27.68% in the last 52 weeks.
| Beta (5Y) | n/a |
| 52-Week Price Change | -27.68% |
| 50-Day Moving Average | 28.04 |
| 200-Day Moving Average | 31.82 |
| Relative Strength Index (RSI) | 28.18 |
| Average Volume (20 Days) | 203 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, SCHOTT Pharma AG & Co. KGaA had revenue of EUR 957.09 million and earned 149.69 million in profits. Earnings per share was 0.99.
| Revenue | 957.09M |
| Gross Profit | 322.61M |
| Operating Income | 188.84M |
| Pretax Income | 183.97M |
| Net Income | 149.69M |
| EBITDA | 249.00M |
| EBIT | 188.84M |
| Earnings Per Share (EPS) | 0.99 |
Balance Sheet
The company has 26.43 million in cash and 286.34 million in debt, giving a net cash position of -259.91 million.
| Cash & Cash Equivalents | 26.43M |
| Total Debt | 286.34M |
| Net Cash | -259.91M |
| Net Cash Per Share | n/a |
| Equity (Book Value) | 792.27M |
| Book Value Per Share | 5.25 |
| Working Capital | 153.12M |
Cash Flow
In the last 12 months, operating cash flow was 225.33 million and capital expenditures -145.08 million, giving a free cash flow of 80.25 million.
| Operating Cash Flow | 225.33M |
| Capital Expenditures | -145.08M |
| Free Cash Flow | 80.25M |
| FCF Per Share | n/a |
Margins
Gross margin is 33.71%, with operating and profit margins of 19.73% and 15.64%.
| Gross Margin | 33.71% |
| Operating Margin | 19.73% |
| Pretax Margin | 19.22% |
| Profit Margin | 15.64% |
| EBITDA Margin | 26.02% |
| EBIT Margin | 19.73% |
| FCF Margin | 8.38% |
Dividends & Yields
SCHOTT Pharma AG & Co. KGaA does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | 15.09% |
| Buyback Yield | n/a |
| Shareholder Yield | n/a |
| Earnings Yield | 4.14% |
| FCF Yield | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | n/a |